News

Tiziana Life Sciences CEO to Speak at Global Bio Convention

Tiziana Life Sciences CEO to Speak at Global Bio Convention

Exciting Developments at the Bio International Convention

Tiziana Life Sciences, Ltd. (NASDAQ: TLSA) is gearing up for a significant presence at the renowned Bio International Convention. The convention serves as a key platform for biotechnology and pharmaceutical companies to showcase their innovations and advancements in healthcare. Ivor Elrifi, the CEO of Tiziana Life Sciences, is set to deliver an insightful oral presentation that will capture the attention of industry leaders and attendees alike.

Focus on Intranasal Foralumab

During his presentation, Mr. Elrifi will delve into the recent clinical findings surrounding Tiziana's lead development candidate, intranasal foralumab. This groundbreaking drug represents a complete shift in the administration of treatments aimed at neuroinflammatory and neurodegenerative diseases. Foralumab is a fully human, anti-CD3 monoclonal antibody that is uniquely administered through the intranasal route, engaging regulatory T cells and thereby offering a new approach to fostering immune tolerance while minimizing systemic immune suppression.

Presentation Details

For those planning to attend, here are the essential details:

Event: Bio International Convention 2025

Presenter: Ivor Elrifi, CEO of Tiziana Life Sciences

Presentation Title: Treatment of Neuroinflammation with Intranasal Foralumab

Date and Time: June 18, 2025, at 11:45 AM ET

Location: Boston Convention & Exhibition Center

Revolutionizing Treatment Approaches

Foralumab's innovative delivery method has shown promising results in clinical settings, particularly for patients with Non-Active Secondary Progressive Multiple Sclerosis. The ongoing Phase 2 trial is currently exploring the therapeutic potential of this treatment for neuroinflammatory conditions, significantly advancing the future of patient care.

In preliminary data, 10 patients participating in an open-label program reported either improvement or stability in their disease condition within a mere six months of treatment, showcasing the efficacy of intranasal foralumab.

The Vision of Tiziana Life Sciences

Tiziana Life Sciences is at the forefront of biopharmaceutical innovation, dedicated to developing transformative therapies that leverage advanced drug delivery technologies. Their approach, particularly the non-systemic administration of therapies like intranasal foralumab, aims to enhance both the efficacy and safety profile compared to traditional intravenous delivery routes.

The company’s proprietary technology is bringing forth a new era in immunotherapy, with several patent applications pending. This pipeline is expected to revolutionize the way immunotherapy is administered across a spectrum of diseases.

Commitment to Innovation

Tiziana Life Sciences continues to strive for breakthroughs in treatment options for various conditions, particularly those affecting the nervous system. The introduction of intranasal foralumab as a clinical development has positioned the company as a leader in addressing unmet medical needs within neuroinflammatory and neurodegenerative domains.

Contact Tiziana Life Sciences

For more details about Tiziana Life Sciences and their pioneering therapeutic pipeline, you can visit their official website. For any inquiries or further information, please reach out directly:

Tiziana Life Sciences Ltd
Paul Spencer, Business Development, and Investor Relations
Phone: +44 (0) 207 495 2379
Email: info@tizianalifesciences.com

Frequently Asked Questions

What is Tiziana Life Sciences known for?

Tiziana Life Sciences specializes in developing innovative immunomodulation therapies, particularly using intranasal delivery methods.

What is intranasal foralumab?

Intranasal foralumab is a fully human anti-CD3 monoclonal antibody designed to treat neuroinflammatory and neurodegenerative diseases.

When will Tiziana present at the Bio International Convention?

Tiziana's CEO will present on June 18, 2025, at 11:45 AM ET during the Bio International Convention.

What are the key benefits of foralumab?

Foralumab promotes immune tolerance and minimizes systemic immune suppression, making it a novel therapy for treating serious conditions.

How can I learn more about Tiziana Life Sciences?

Visit Tiziana Life Sciences' website or contact them for detailed information about their therapies and research activities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 350

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 254

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 224

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 197

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 246

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 303

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 334

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 239

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 96

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 220

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading

Top 5 Most Recently Viewed Articles

Coro Expands Its Cybersecurity Reach with EMEA Office Opening

Updated Category News Views 233

Coro Enters EMEA Market with London Office Launch Coro, a prominent cybersecurity platform known for supporting small and midsize businesses, has taken a significant leap in its growth story with the establishment of a new office in London. This expansion marks a noteworthy commitment to the EMEA region and reflects the company's dedication to addressing the evolving...

Continue Reading
Porsche AG Eyes Restructuring Amid Market Challenges Ahead

Updated Category News Views 260

Porsche AG Implements Extensive Restructuring Plan Luxury sports car manufacturer Porsche AG is undergoing a significant restructuring initiative aimed at improving efficiency and ensuring long-term financial stability. The company is poised to cut approximately 1,900 positions by the year 2029 as part of its strategy to navigate challenging market conditions. Job...

Continue Reading
Enveda Boosts Leadership Team with Jason Kim as CFO

Updated Category News Views 544

Enveda Boosts Leadership Team with Jason Kim as CFO Enveda, a pioneering biotechnology firm that harnesses artificial intelligence to decode nature’s complex chemistry into groundbreaking medicines, has made a significant addition to its executive team. Jason Kim has been appointed as the new Chief Financial Officer (CFO), bringing along a wealth of experience earned...

Continue Reading
NewGen IVF Group: Pioneering Solutions Across Diverse Markets

Updated Category News Views 157

NewGen IVF Group's Innovative Journey NewGen IVF Group Limited (NASDAQ: NIVF) is making waves as a forward-thinking powerhouse in several key sectors. With a focus on technology and growth, this company is transforming industries such as real estate development, digital asset management, and reproductive health solutions. By leveraging innovative strategies, NewGen is...

Continue Reading
Ethical Web AI Welcomes Peter Varnish OBE to Its Advisory Board

Updated Category News Views 256

Ethical Web AI Welcomes New Advisory Board Member Ethical Web AI, known for its innovative approach in ethical technology, has recently made a significant addition to its team by appointing Peter Varnish OBE as a member of its Advisory Board. This strategic move is expected to bolster the company's efforts in revolutionizing the digital landscape while aligning with its...

Continue Reading